These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 459691)

  • 21. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    J Neurochem; 1977 Jan; 28(1):227-8. PubMed ID: 833596
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings.
    Leysen JE; Eens A; Gommeren W; Van Gompel P; Wynants J; Janssen PA
    Eur J Pharmacol; 1987 Feb; 134(3):373-5. PubMed ID: 3569421
    [No Abstract]   [Full Text] [Related]  

  • 24. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH; Murrin LC; Walters JR
    Eur J Pharmacol; 1976 Mar; 36(1):163-71. PubMed ID: 177297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of penfluridol on circling behavior and striatal DOPAC and serum prolactin concentrations in the rat.
    Annunziato LA; Wuerthele SM; Moore KE
    Eur J Pharmacol; 1978 Aug; 50(3):187-92. PubMed ID: 567584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry.
    Gonzalez-Mora JL; Sanchez-Bruno JA; Mas M
    Neurosci Lett; 1988 Mar; 86(1):61-6. PubMed ID: 3362430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metoclopramide induces catalepsy and increases striatal homovanillic acid content in mice.
    Ahtee L; Buncombe G
    Acta Pharmacol Toxicol (Copenh); 1974 Nov; 35(5):429-32. PubMed ID: 4479719
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 31. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evidence for a specific relationship between consciousness status and striatal levels of ascorbic acid: is it an indicator of their functional intermodulation?].
    Crespi F
    Medicina (Firenze); 1988; 8(4):448-51. PubMed ID: 2468984
    [No Abstract]   [Full Text] [Related]  

  • 34. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple in vitro technique to measure the release of endogenous dopamine and dihydroxyphenylacetic acid from striatal tissue using high performance liquid chromatography with electrochemical detection.
    Becker JB; Castañeda E; Robinson TE; Beer ME
    J Neurosci Methods; 1984 May; 11(1):19-28. PubMed ID: 6471905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanocyproheptadine: role of cholinolytic properties in modulating neuroleptic-induced elevation of striatal homovanillic acid (HVA).
    Robinson SE; Lotti VJ; Sulser F
    J Pharm Pharmacol; 1977 Sep; 29(9):564-6. PubMed ID: 21265
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine concentrations in brain regions: relationship to dopamine metabolite increase.
    Wilk S; Stanley M
    Eur J Pharmacol; 1978 Sep; 51(2):101-7. PubMed ID: 699976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.